Lower riskDrug recall · FDA · Published January 5, 2024
Lupin Rifampin Capsules Recall: Subpotent Drug Risk
Lupin Pharmaceuticals recalls 150mg Rifampin Capsules (30-count) due to subpotent drug and failed impurities. Rx-only product with specific batch numbers. Contact for return instructions.
Subpotent Drug and Failed Impurities/Degradation Specifications
Take action
Contact the company
📍Recalling firmLupin Pharmaceuticals Inc.Harborplace Tower, 111 S Calvert St Fl 21st · Baltimore, MD 21202-6174
✎ GovInfoNow plain-language explainer
Lup: Lupin Pharmaceuticals is recalling 150mg Rifampin Capsules (30-count bottles) because they may not contain the correct amount of active ingredient and have failed quality tests. This could lead to ineffective treatment if used as prescribed. Read more at govinfonow.com/recall/32889-lupin-rifampin-capsules-recall-subpotent-drug-risk.
“Lupin Rifampin Capsules Recall: Subpotent Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32889-lupin-rifampin-capsules-recall-subpotent-drug-risk. Based on FDA recall #D-0283-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0283-2024%22&limit=1).
The FDA announced on Jan. 5, 2024, that Lupin Pharmaceuticals Inc. is recalling Rifampin Capsules USP 150mg due to subpotent drug and failed impurities specifications. The voluntary Class II recall affects 15,576 bottles distributed to wholesale accounts.
Lot codes: A200816 (exp 1/2024), A201248 (exp 3/2024)
Quantity: 15,576 bottles
The hazard
The recall is due to the product being subpotent and failing impurities or degradation specifications. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Lupin Pharmaceuticals Inc. has had 90 other recalls since Jan. 31, 2013. Recent brand recalls include a Lupin Clobetasol Cream recall on Aug. 3, 2026, for failed content uniformity, and a Lupin Glucagon Emergency Kit recall on June 23, 2026, for CGMP deviation risk. Other recent recalls of similar products include Sun Pharmaceutical Lisdexamfetamine Capsules Recall (Oct. 28, 2025), Unichem busPIRone 5mg Tablets Recall (April 13, 2026), and Bell Pharmaceuticals Clinere Carbamide Peroxide Recall (June 25, 2026).
How to tell if you have this one
Check for the 30-count bottle labeled 'Rifampin Capsules USP 150mg', Rx Only. Look for batch numbers A200816 (exp 1/2024) or A201248 (exp 3/2024) on the packaging.
Brand
Lupin Pharmaceuticals
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Terminated
Distribution
Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0283-2024 (January 5, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0283-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.